News Related to Erythromycin

Related coverage linked through entity extraction aliases.

GC Biopharma review summarizes 30 years of MAV/06 varicella vaccine data

Apr 07, 2026

GC Biopharma said a review paper in Human Vaccines & Therapeutics analyzed more than 40 studies on its MAV/06 varicella vaccine strain. The paper summarized 30 years of data showing 99-100% neutralizing antibody rates and adverse event incidence of 0.41 to 0.57 cases per 100,000 doses.

Antimicrobial Resistance in Foodborne Bacteria Remains High Across Europe

Feb 18, 2026

A joint report from the European Food Safety Authority and the European Centre for Disease Prevention and Control finds antimicrobial resistance in Salmonella and Campylobacter continues to pose a public health concern across Europe, though several countries have reported progress in reducing resistance levels.